000 | 01776 a2200505 4500 | ||
---|---|---|---|
005 | 20250516081948.0 | ||
264 | 0 | _c20130604 | |
008 | 201306s 0 0 eng d | ||
022 | _a1476-5594 | ||
024 | 7 |
_a10.1038/onc.2012.60 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShchors, K | |
245 | 0 | 0 |
_aIncreased invasiveness of MMP-9-deficient tumors in two mouse models of neuroendocrine tumorigenesis. _h[electronic resource] |
260 |
_bOncogene _cJan 2013 |
||
300 |
_a502-13 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCD11b Antigen _xgenetics |
650 | 0 | 4 |
_aCathepsin B _xgenetics |
650 | 0 | 4 |
_aCell Transformation, Neoplastic _xdrug effects |
650 | 0 | 4 |
_aCysteine _xgenetics |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aGTPase-Activating Proteins _xgenetics |
650 | 0 | 4 |
_aInflammation _xgenetics |
650 | 0 | 4 |
_aInterleukin-1beta _xgenetics |
650 | 0 | 4 |
_aLeukocytes _xdrug effects |
650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xdeficiency |
650 | 0 | 4 |
_aMatrix Metalloproteinase Inhibitors _xpharmacology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aNeoplasm Invasiveness |
650 | 0 | 4 |
_aNeovascularization, Pathologic _xgenetics |
650 | 0 | 4 |
_aNeuroendocrine Tumors _xblood supply |
650 | 0 | 4 |
_aPancreatic Neoplasms _xblood supply |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-myc _xgenetics |
650 | 0 | 4 |
_abcl-X Protein _xgenetics |
700 | 1 | _aNozawa, H | |
700 | 1 | _aXu, J | |
700 | 1 | _aRostker, F | |
700 | 1 | _aSwigart-Brown, L | |
700 | 1 | _aEvan, G | |
700 | 1 | _aHanahan, D | |
773 | 0 |
_tOncogene _gvol. 32 _gno. 4 _gp. 502-13 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/onc.2012.60 _zAvailable from publisher's website |
999 |
_c21597851 _d21597851 |